Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis.
about
Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Everolimus in advanced, progre ...... IANT-4 lung subgroup analysis.
@en
Everolimus in advanced, progre ...... IANT-4 lung subgroup analysis.
@nl
type
label
Everolimus in advanced, progre ...... IANT-4 lung subgroup analysis.
@en
Everolimus in advanced, progre ...... IANT-4 lung subgroup analysis.
@nl
prefLabel
Everolimus in advanced, progre ...... IANT-4 lung subgroup analysis.
@en
Everolimus in advanced, progre ...... IANT-4 lung subgroup analysis.
@nl
P2093
P2860
P356
P1433
P1476
Everolimus in advanced, progre ...... IANT-4 lung subgroup analysis.
@en
P2093
Antonia Ridolfi
Edward Wolin
Eric Van Cutsem
Fabian Herbst
Gianfranco Delle Fave
James C Yao
Jiri Tomasek
Jonathan Strosberg
Juan W Valle
Lida Bubuteishvili-Pacaud
P2860
P304
P356
10.1111/CAS.13427
P50
P577
2017-10-21T00:00:00Z